Listed

Ducommun Inc: Form 10-Q for the period ended Oct 1, 2022

Filed with the SEC on Nov 7, 2022 and accepted by EDGAR at Nov 7, 2022, 06:36 ET.

Share

Management's discussion and analysis

As filed, 47,636 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Overview

Ducommun Incorporated (“Ducommun,” “the Company,” “we,” “us” or “our”) is a leading global provider of engineering and manufacturing services for high-performance products and high-cost-of failure applications used primarily in the aerospace and defense (“A&D”), industrial, medical and other industries (collectively, “Industrial”). We differentiate ourselves as a full-service solution-based provider, offering a wide range of value-added products and services in our primary businesses of electronics, structures and integrated solutions. We operate through two primary business segments: Electronic Systems and Structural Systems, each of which is a reportable segment.

COVID-19 Pandemic Impact on Our Business

The COVID-19 pandemic has had a significant impact on our overall business during both the three and nine months ended October 1, 2022 and October 2, 2021. As a result of the COVID-19 pandemic, precautionary measures were instituted by governments and businesses to mitigate its spread, including the imposition of travel restrictions, quarantines, shelter in place directives, and shutting down of non-essential businesses.

The safety of our employees remains our highest priority. The well-being and safety protocols that were already in place at all of our facilities were further enhanced at the onset of the COVID-19 pandemic. We continue to follow safety protocols consistent with guidelines provided by state and local governments and the Centers for Disease Control and Prevention (“CDC”). These measures included social distancing, provision of personal protective equipment, enhanced cleaning, and flexible work arrangements wherever possible. We have also offered enhanced leave and benefits to our employees and provided frequent updates to ensure our workforce is kept apprised of evolving regulations and safety measures.

In March 2020, the U.S. enacted the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) which provides tax relief to individuals and businesses affected by the coronavirus pandemic. We have not requested or accepted any loans or payments that are available under the CARES Act, however, we have utilized the option to defer payment of the employer portion of payroll taxes (Social Security) that would otherwise be required to be made during the period beginning March 27, 2020 to December 31, 2020. One half of the deferred amount was required to be paid and was paid by December 31, 2021, with the remaining 50% to be paid by December 31, 2022. As of October 1, 2022, we have deferred $3.1 million, which is included as part of accrued and other liabilities on the condensed consolidated balance sheets.

The COVID-19 pandemic has and continues to contribute to a general slowdown in the global economy and most significantly, the commercial aerospace end-use market. While both major large aircraft manufacturers, The Boeing Company (“Boeing”) and Airbus SE, have announced increases in build rates for 2022, it is well below pre-pandemic levels. In its 2021 Annual Report on Form 10-K, Boeing indicated it expects commercial air travel to return to 2019 levels in 2023 to 2024, and a few years beyond that for the industry to return to the long-term trend growth. While the full extent and impact of the COVID-19 pandemic cannot be reasonably estimated with certainty at this time, COVID-19 has had a significant impact on our business, the businesses of our customers and suppliers, as well as our results of operations and financial condition, and may have a material adverse impact on our business, results of operations and financial condition for 2022 and beyond.

Third quarter 2022 recap:

  • Net revenues of $186.6 million
  • Net income of $8.5 million, or $0.69 per diluted share
  • Adjusted EBITDA of $26.0 million, or 13.9% of revenues

Non-GAAP Financial Measures

Adjusted earnings before interest, taxes, depreciation, amortization, stock-based compensation expense, restructuring charges, Guaymas fire related expenses, insurance recoveries related to business interruption, inventory purchase accounting adjustments, loss on extinguishment of debt, and other debt refinancing costs (“Adjusted EBITDA”) were $26.0 million and $23.9 million for the three months ended October 1, 2022 and October 2, 2021, respectively.

When viewed with our financial results prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and accompanying reconciliations, we believe Adjusted EBITDA provides additional useful information that clarifies and enhances the understanding of the factors and trends affecting our past performance and future prospects. We define this measure, explain how it is calculated and provide a reconciliation of this measure to the most comparable GAAP measure in the table below. Adjusted EBITDA and the related financial ratios, as presented in this Quarterly Report on Form 10-Q (“Form 10-Q”), are supplemental measures of our performance that are not required by, or presented in accordance with, GAAP. They are not a measurement of our financial performance under GAAP and should not be considered as alternatives to net income or any other performance measures derived in accordance with GAAP, or as an alternative to net cash provided by operating activities as measures of our liquidity. The presentation of these measures should not be interpreted to mean that our future results will be unaffected by unusual or nonrecurring items.

We use Adjusted EBITDA as a non-GAAP operating performance measure internally as a complementary financial measure to evaluate the performance and trends of our businesses. We present Adjusted EBITDA and the related financial ratios, as applicable, because we believe that measures such as these provide useful information with respect to our ability to meet our operating commitments.

Adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations include:

  • It does not reflect our cash expenditures, future requirements for capital expenditures or contractual commitments;
  • It does not reflect changes in, or cash requirements for, our working capital needs;
  • It does not reflect the significant interest expense or the cash requirements necessary to service interest or principal payments on our debt;
  • Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements;
  • It is not adjusted for all non-cash income or expense items that are reflected in our statements of cash flows;
  • It does not reflect the impact on earnings of charges resulting from matters unrelated to our ongoing operations; and
  • Other companies in our industry may calculate Adjusted EBITDA differently from us, limiting its usefulness as a comparative measure.

As a result of these limitations, Adjusted EBITDA and the related financial ratios should not be considered as measures of discretionary cash available to us to invest in the growth of our business or as a measure of cash that will be available to us to meet our obligations. You should compensate for these limitations by relying primarily on our GAAP results and using Adjusted EBITDA only as supplemental information. See our condensed consolidated financial statements contained in this Form 10-Q.

Even with the limitations above, we believe that Adjusted EBITDA is useful to an investor in evaluating our results of operations as this measure:

  • Is widely used by investors to measure a company’s operating performance without regard to items excluded from the calculation of such terms, which can vary substantially from company to company depending upon accounting methods and book value of assets, capital structure and the method by which assets were acquired, among other factors;
  • Helps investors to evaluate and compare the results of our operations from period to period by removing the effect of our capital structure from our operating performance; and
  • Is used by our management team for various other purposes in presentations to our Board of Directors as a basis for strategic planning and forecasting.

The following financial items have been added back to or subtracted from our net income when calculating Adjusted EBITDA:

  • Interest expense may be useful to investors for determining current cash flow;
  • Income tax expense may be useful to investors because it represents the taxes which may be payable for the period and the change in deferred taxes during the period, and may reduce cash flow available for use in our business;
  • Depreciation may be useful to investors because it generally represents the wear and tear on our property and equipment used in our operations;
  • Amortization expense may be useful to investors because it represents the estimated attrition of our acquired customer base and the diminishing value of product rights;
  • Stock-based compensation may be useful to our investors for determining current cash flow;
  • Restructuring charges may be useful to our investors in evaluating our core operating performance;
  • Guaymas fire related expenses may be useful to our investors in evaluating our core operating performance;
  • Insurance recoveries related to business interruption may be useful to our investors in evaluating our core operating performance;
  • Purchase accounting inventory step-ups may be useful to our investors as they do not necessarily reflect the current or on-going cash charges related to our core operating performance;
  • Loss on extinguishment of debt may be useful to our investors for determining current cash flow; and
  • Other debt refinancing costs may be useful to our investors in evaluating our core operating performance.

Reconciliations of net income to Adjusted EBITDA and the presentation of Adjusted EBITDA as a percentage of net revenues were as follows:

(Dollars in thousands)

(Dollars in thousands)

Three Months Ended October 1, 2022 October 2, 2021 Nine Months Ended October 1, 2022 October 2, 2021
Net income $8,462 $9,584 $20,708 $24,702
Interest expense 2,998 2,770 8,056 8,433
Income tax expense 1,462 1,205 4,035 4,126
Depreciation 3,652 3,632 10,849 10,530
Amortization 4,017 3,572 12,486 10,582
Stock-based compensation expense (1) 2,714 2,407 7,904 8,149
Restructuring charges (2) 567 — 3,798 —
Guaymas fire related expenses 1,496 704 3,451 1,871
Insurance recoveries related to business interruption — — (3,000) —
Inventory purchase accounting adjustments 107 — 1,381 —
Loss on extinguishment of debt 295 — 295 —
Other debt refinancing costs 224 — 224 —
Adjusted EBITDA $25,994 $23,874 $70,187 $68,393
% of net revenues 13.9% 14.6% 13.4% 14.2%

(1) The three and nine months ended October 1, 2022 included $0.2 million and $0.8 million, respectively, of stock-based compensation expense for awards with both performance and market conditions that will be settled in cash.

(2) The three and nine months ended October 1, 2022 included zero and $0.5 million, respectively, of restructuring charges that were recorded as cost of sales.

Results of Operations

Third Quarter of 2022 Compared to Third Quarter of 2021

The following table sets forth net revenues, selected financial data, the effective tax rate and diluted earnings per share:

(Dollars in thousands, except per share data) Three Months Ended October 1, 2022 % of Net Revenues October 2, 2021 % of Net Revenues (Dollars in thousands, except per share data) Nine Months Ended October 1, 2022 % of Net Revenues October 2, 2021 % of Net Revenues
Net Revenues $186,590 100.0% $163,227 100.0% $524,269 100.0% $480,570 100.0%
Cost of Sales 148,003 79.3% 127,912 78.4% 418,565 79.8% 375,373 78.1%
Gross Profit 38,587 20.7% 35,315 21.6% 105,704 20.2% 105,197 21.9%
Selling, General and Administrative Expenses 24,803 13.3% 21,952 13.4% 72,340 13.8% 68,132 14.2%
Restructuring Charges 567 0.3% — —% 3,270 0.7% — —%
Operating Income 13,217 7.1% 13,363 8.2% 30,094 5.7% 37,065 7.7%
Interest Expense (2,998) (1.6)% (2,770) (1.7)% (8,056) (1.5)% (8,433) (1.7)%
Loss on Extinguishment of Debt (295) (0.2)% — —% (295) (0.1)% — —%
Other Income — —% 196 0.1% 3,000 0.6% 196 —%
Income Before Taxes 9,924 5.3% 10,789 6.6% 24,743 4.7% 28,828 6.0%
Income Tax Expense 1,462 nm 1,205 nm 4,035 nm 4,126 nm
Net Income $8,462 4.5% $9,584 5.9% $20,708 3.9% $24,702 5.1%
Effective Tax Rate 14.7% nm 11.2% nm 16.3% nm 14.3% nm
Diluted Earnings Per Share $0.69 nm $0.78 nm $1.68 nm $2.02 nm

nm = not meaningful

Net Revenues by End-Use Market and Operating Segment

Net revenues by end-use market and operating segment during the fiscal three and nine months ended October 1, 2022 and October 2, 2021, respectively, were as follows:

(Dollars in thousands)

(Dollars in thousands)

Consolidated Ducommun Three Months Ended Change October 1, 2022 October 2, 2021 % of Net Revenues October 1, 2022 October 2, 2021 Nine Months Ended Change October 1 2022 October 2, 2021 % of Net Revenues October 1 2022 October 2, 2021
Military and space $(7,319) $106,303 $113,622 57.0% 69.6% $(28,440) $312,317 $340,757 59.6% 70.9%
Commercial aerospace 27,198 68,348 41,150 36.6% 25.2% 65,386 179,490 114,104 34.2% 23.7%
Industrial 3,484 11,939 8,455 6.4% 5.2% 6,753 32,462 25,709 6.2% 5.4%
Total $23,363 $186,590 $163,227 100.0% 100.0% $43,699 $524,269 $480,570 100.0% 100.0%
Electronic Systems
Military and space $(2,554) $78,811 $81,365 69.5% 77.7% $(13,035) $230,818 $243,853 72.0% 79.5%
Commercial aerospace 7,753 22,654 14,901 20.0% 14.2% 20,262 57,322 37,060 17.9% 12.1%
Industrial 3,484 11,939 8,455 10.5% 8.1% 6,753 32,462 25,709 10.1% 8.4%
Total $8,683 $113,404 $104,721 100.0% 100.0% $13,980 $320,602 $306,622 100.0% 100.0%
Structural Systems
Military and space $(4,765) $27,492 $32,257 37.6% 55.1% $(15,405) $81,499 $96,904 40.0% 55.7%
Commercial aerospace 19,445 45,694 26,249 62.4% 44.9% 45,124 122,168 77,044 60.0% 44.3%
Total $14,680 $73,186 $58,506 100.0% 100.0% $29,719 $203,667 $173,948 100.0% 100.0%

Net revenues for the three months ended October 1, 2022 were $186.6 million, compared to $163.2 million for the three months ended October 2, 2021. The year-over-year increase was primarily due to the following:

  • $27.2 million higher revenues in our commercial aerospace end-use markets due to higher build rates on large aircraft platforms, other commercial aerospace platforms, and regional and business aircraft platforms; partially offset by
  • $7.3 million lower revenues in our military and space end-use markets due to lower build rates on military rotary-wing aircraft platforms and military fixed-wing aircraft platforms, partially offset by higher build rates on other military and space platforms.

Net revenues for the nine months ended October 1, 2022 were $524.3 million, compared to $480.6 million for the nine months ended October 2, 2021. The year-over-year increase was primarily due to the following:

  • $65.4 million higher revenues in our commercial aerospace end-use markets due to higher build rates on large aircraft platforms, other commercial aerospace platforms, and regional and business aircraft platforms; partially offset by
  • $28.4 million lower revenues in our military and space end-use markets due to lower build rates on military rotary-wing aircraft platforms, military fixed-wing aircraft platforms, and various missile platforms.

Net Revenues by Major Customers

A significant portion of our net revenues are from our top ten customers as follows:

Three Months Ended October 1, 2022 October 2, 2021 Nine Months Ended October 1, 2022 October 2, 2021
Boeing Company 7.2% 8.7% 6.9% 8.4%
General Dynamics Corporation 6.0% 3.0% 5.7% 2.8%
Northrop Grumman Corporation 5.1% 6.6% 5.8% 6.7%
Raytheon Technologies Corporation 20.6% 25.0% 21.0% 23.3%
Spirit AeroSystems Holdings, Inc. 6.8% 5.3% 5.7% 3.9%
Viasat, Inc. 5.7% 2.4% 4.7% 2.7%
Total top ten customers (1) 63.9% 62.4% 60.9% 60.4%

29

(1) Includes The Boeing Company (“Boeing”), General Dynamics Corporation (“GD”), Northrop Grumman Corporation (“Northrop”), Raytheon Technologies Corporation (“Raytheon”), Spirit AeroSystems Holdings, Inc. (“Spirit”), and Viasat, Inc. (“Viasat”) for the three and nine months ended October 1, 2022 and October 2, 2021.

Boeing, GD, Northrop, Raytheon, Spirit, and Viasat represented the following percentages of total accounts receivable:

October 1, 2022 December 31, 2021
Boeing 3.4% 3.5%
GD 5.9% 4.0%
Northrop 6.4% 10.9%
Raytheon 12.2% 17.8%
Spirit 1.3% 0.7%
Viasat 7.6% 4.3%

The net revenues and accounts receivable from Boeing, GD, Northrop, Raytheon, Spirit, and Viasat are diversified over a number of commercial, military and space programs and were generated by both operating segments.

Gross Profit

Gross profit consists of net revenues less cost of sales. Cost of sales includes the cost of production of finished products and other expenses related to inventory management, manufacturing quality, and order fulfillment. Gross profit as a percentage of net revenues decreased year-over-year with the three months ended October 1, 2022 of 20.7%, compared to the three months ended October 2, 2021 of 21.6% primarily due to unfavorable product mix, partially offset by favorable manufacturing volume.

Gross profit as a percentage of net revenues decreased year-over-year with the nine months ended October 1, 2022 of 20.2%, compared to the nine months ended October 2, 2021 of 21.9% primarily due to unfavorable product mix, partially offset by favorable manufacturing volume and lower compensation and benefits costs.

Selling, General and Administrative (“SG&A”) Expenses

SG&A expenses increased $2.9 million year-over-year in the three months ended October 1, 2022 compared to the three months ended October 2, 2021 primarily due to higher compensation and benefits costs of $2.0 million and higher other general and administrative expenses of $1.0 million.

SG&A expenses increased $4.2 million year-over-year in the nine months ended October 1, 2022 compared to the nine months ended October 2, 2021 primarily due to higher other general and administrative expenses of $3.0 million and higher compensation and benefits costs of $1.8 million.

Restructuring Charges

Restructuring charges increased $0.6 million and $3.8 million (of which, zero and $0.5 million, respectively, was included in cost of sales) year-over-year in the three and nine months ended October 1, 2022, respectively, compared to both the three and nine months ended October 2, 2021, respectively, primarily due to the restructuring plan that was approved and commenced in April 2022 that is expected to better position us for stronger performance. See Note 3 for further information.

Interest Expense

Interest expense increased $0.2 million year-over-year in the three months ended October 1, 2022 compared to the three months ended October 2, 2021 primarily due to higher interest rates, partially offset by a lower outstanding debt balance.

Interest expense decreased $0.4 million year-over-year in the nine months ended October 1, 2022 compared to the nine months ended October 2, 2021 primarily due to a lower outstanding debt balance, partially offset by higher interest rates.

Income Tax Expense

We recorded income tax expense of $1.5 million for the three months ended October 1, 2022, compared to $1.2 million for the three months ended October 2, 2021. The increase in income tax expense for the third quarter of 2022 compared to the third quarter of 2021 was primarily due to lower income tax benefits recognized related to the U.S. Federal research and development tax credit in the third quarter of 2022 compared to the third quarter of 2021. The increase in income tax expense was partially offset by lower pre-tax income in the third quarter of 2022.

We recorded income tax expense of $4.0 million for the nine months ended October 1, 2022, compared to $4.1 million for the nine months ended October 2, 2021. The decrease in income tax expense for the first nine months of 2022 compared to the first nine months of 2021 was primarily due to lower pre-tax income in the first nine months of 2022 compared to the first nine months of 2021. The decrease in income tax expense was partially offset by lower income tax benefits recognized related to the U.S. Federal research and development tax credit and lower discrete income tax benefits recognized for net tax windfalls related to stock-based compensation in the first nine months of 2022.

Our total amount of unrecognized tax benefits was $4.8 million and $4.4 million as of October 1, 2022 and December 31, 2021, respectively. If recognized, $3.0 million would affect the effective tax rate. We record interest and penalty charges, if any, related to uncertain tax positions as a component of tax expense and unrecognized tax benefits. The amounts accrued for interest and penalty charges as of October 1, 2022 and December 31, 2021 were not significant. As a result of statute of limitations set to expire in the fourth quarter of 2022, we expect decreases to our unrecognized tax benefits of approximately $0.7 million in the next twelve months.

We file U.S. Federal and state income tax returns. We are subject to examination by the Internal Revenue Service (“IRS”) for tax years after 2017 and by state taxing authorities for tax years after 2016. While we are no longer subject to examination prior to those periods, carryforwards generated prior to those periods may still be adjusted upon examination by the IRS or state taxing authorities if they either have been or will be used in a subsequent period. We believe we have adequately accrued for tax deficiencies or reductions in tax benefits, if any, that could result from the examination and all open audit years.

The Tax Cuts and Jobs Act of 2017 (“TCJA”), which was signed into U.S. law in December 2017, eliminated the option to immediately deduct research and development expenditures in the year incurred under Section 174 effective January 1, 2022. The amended provision under Section 174 requires us to capitalize and amortize these expenditures over five years (for U.S.-based research). As of October 1, 2022, we recorded an increase to current income taxes payable of approximately $7.5 million and a decrease to net deferred tax liabilities of a similar amount. We are monitoring legislation for any further changes to Section 174 and the impact to the financial statements in 2022.

On August 9, 2022, the U.S. enacted the Creating Helpful Incentives to Produce Semiconductors Act of 2022 (“CHIPS Act”) which provides new funding to boost domestic research and manufacturing of semiconductors in the United States. We are evaluating the provisions in the CHIPS Act. Any impact to our overall income taxes would be for 2023 and thereafter.

On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022 (“IRA”) which aims to curb inflation by reducing the deficit, lowering prescription drug prices, and investing in domestic energy production while promoting clean energy. We considered the provisions in the IRA and determined they have no or minimal impact to our overall income taxes.

Net Income and Earnings per Share

Net income and earnings per share for the three months ended October 1, 2022 were $8.5 million, or $0.69 per diluted share, compared to $9.6 million, or $0.78 per diluted share, for the three months ended October 2, 2021. The decrease in net income for the three months ended October 1, 2022 compared to the three months ended October 2, 2021 was primarily due to higher SG&A expenses of $2.9 million, partially offset by higher gross profit of $3.3 million.

Net income and earnings per share for the nine months ended October 1, 2022 were $20.7 million, or $1.68 per diluted share, compared to $24.7 million, or $2.02 per diluted share, for the nine months ended October 2, 2021. The decrease in net income for the nine months ended October 1, 2022 compared to the nine months ended October 2, 2021 was primarily due to higher SG&A expenses of $4.2 million and higher restructuring charges of $3.8 million ($0.5 million was included as part of cost of sales), partially offset by higher other income of $2.8 million.

Business Segment Performance

We report our financial performance based upon the two reportable operating segments: Electronic Systems and Structural Systems. The results of operations differ between our reportable operating segments due to differences in competitors, customers, extent of proprietary deliverables and performance. The following table summarizes our business segment performance for the three and nine months ended October 1, 2022 and October 2, 2021:

(Dollars in thousands)

(Dollars in thousands)

Net Revenues Three Months Ended % Change October 1, 2022 October 2, 2021 % of Net Revenues% October 1, 2022 October 2, 2021 Nine Months Ended Change October 1, 2022 October 2, 2021 % of Net Revenues October 1, 2022 October 2, 2021
Electronic Systems 8.3% $113,404 $104,721 60.8% 64.2% 4.6% $320,602 $306,622 61.2% 63.8%
Structural Systems 25.1% 73,186 58,506 39.2% 35.8% 17.1% 203,667 173,948 38.8% 36.2%
Total Net Revenues 14.3% $186,590 $163,227 100.0% 100.0% 9.1% $524,269 $480,570 100.0% 100.0%
Segment Operating Income
Electronic Systems $13,881 $15,319 12.2% 14.6% $36,902 $42,185 11.5% 13.8%
Structural Systems 6,687 4,457 9.1% 7.6% 12,839 15,177 6.3% 8.7%
20,568 19,776 49,741 57,362
Corporate General and Administrative Expenses (1) (7,351) (6,413) (3.9)% (3.9)% (19,647) (20,297) (3.7)% (4.2)%
Total Operating Income $13,217 $13,363 7.1% 8.2% $30,094 $37,065 5.7% 7.7%
Adjusted EBITDA
Electronic Systems
Operating Income $13,881 $15,319 $36,902 $42,185
Other Income — 196 — 196
Depreciation and Amortization 3,510 3,547 10,500 10,396
Restructuring Charges 340 — 1,624 —
17,731 19,062 15.6% 18.2% 49,026 52,777 15.3% 17.2%
Structural Systems
Operating Income 6,687 4,457 12,839 15,177
Depreciation and Amortization 4,100 3,599 12,659 10,540
Restructuring Charges 227 — 2,174 —
Guaymas fire related expenses 1,496 704 3,451 1,871
Inventory Purchase Accounting Adjustments 107 — 1,381 —
12,617 8,760 17.2% 15.0% 32,504 27,588 16.0% 15.9%
Corporate General and Administrative Expenses (1)
Operating Loss (7,351) (6,413) (19,647) (20,297)
Depreciation and Amortization 59 58 176 176
Stock-Based Compensation Expense 2,714 2,407 7,904 8,149
Other Debt Refinancing Costs 224 — 224 —
(4,354) (3,948) (11,343) (11,972)
Adjusted EBITDA $25,994 $23,874 13.9% 14.6% $70,187 $68,393 13.4% 14.2%
Capital Expenditures
Electronic Systems $3,192 $1,964 $7,831 $3,865
Structural Systems 1,175 1,598 7,033 6,154
Corporate Administration — — — —
Total Capital Expenditures $4,367 $3,562 $14,864 $10,019

(1) Includes costs not allocated to either the Electronic Systems or Structural Systems operating segments.

Electronic Systems

Electronic Systems net revenues in the three months ended October 1, 2022 compared to the three months ended October 2, 2021 increased $8.7 million primarily due to the following:

  • $7.8 million higher revenues in our commercial aerospace end-use markets due to higher build rates on other commercial aerospace platforms and regional and business aircraft platforms; partially offset by
  • $2.6 million lower revenues in our military and space end-use markets due to lower build rates on military fixed-wing aircraft platforms, partially offset by higher build rates on other military and space platforms.

Electronic Systems net revenues in the nine months ended October 1, 2022 compared to the nine months ended October 2, 2021 increased $14.0 million primarily due to the following:

  • $20.3 million higher revenues in our commercial aerospace end-use markets due to higher build rates on other commercial aerospace platforms, regional and business aircraft platforms, and large aircraft platforms; partially offset by
  • $13.0 million lower revenues in our military and space end-use markets due to lower build rates on military fixed-wing aircraft platforms and various missile platforms.

Electronic Systems segment operating income in the three months ended October 1, 2022 compared to the three months ended October 2, 2021 decreased $1.4 million primarily due to unfavorable product mix, partially offset by favorable manufacturing volume.

Electronic Systems segment operating income in the nine months ended October 1, 2022 compared to the nine months ended October 2, 2021 decreased $5.3 million primarily due to unfavorable product mix, partially offset by favorable manufacturing volume.

Structural Systems

Structural Systems net revenues in the three months ended October 1, 2022 compared to the three months ended October 2, 2021 increased $14.7 million primarily due to the following:

  • $19.4 million higher revenues in our commercial aerospace end-use markets due to higher build rates on large aircraft platforms, other commercial aerospace platforms, and regional and business aircraft platforms; partially offset by
  • $4.8 million lower revenues in our military and space end-use markets due to lower build rates on military rotary-wing aircraft platforms, partially offset by higher build rates on military fixed-wing aircraft platforms.

Structural Systems net revenues in the nine months ended October 1, 2022 compared to the nine months ended October 2, 2021 increased $29.7 million primarily due to the following:

  • $45.1 million higher revenues in our commercial aerospace end-use markets due to higher build rates on large aircraft platforms, regional and business aircraft platforms, and other commercial aerospace platforms; partially offset by
  • $15.4 million lower revenues in our military and space end-use markets due to lower build rates on military rotary-wing aircraft platforms, partially offset by higher build rates on military fixed-wing aircraft platforms.

The Structural Systems segment operating income in the three months ended October 1, 2022 compared to the three months ended October 2, 2021 increased $2.2 million primarily due to favorable manufacturing volume.

The Structural Systems segment operating income in the nine months ended October 1, 2022 compared to the nine months ended October 2, 2021 decreased $2.3 million primarily due to unfavorable manufacturing volume, partially offset by lower compensation and benefits costs and favorable product mix.

In June 2020, a fire severely damaged our performance center in Guaymas, Mexico. We have insurance coverage and up to a capped amount, expect these items will be covered, less our deductible. The full financial impact cannot be estimated at this time as we are currently working with our insurance carriers to determine the cause of the fire. The loss of production from the Guaymas performance center was being absorbed by our other existing performance centers, however, we have reestablished and are in the process of ramping up our manufacturing capabilities in a different leased facility in Guaymas. A neighboring, non-related manufacturing facility, also suffered fire damage during the same time as the fire that severely damaged our Guaymas performance center. The cause of the fire is still undetermined and as such, there is no amount of loss that is probable and reasonably estimable at this time. If we are ultimately deemed to be responsible or partly responsible, it is possible we could incur a loss in excess of our insurance coverage limits, which could be material to our cash flow, liquidity, or financial results. See Note 8 and Note 10 to our condensed consolidated financial statements included in Part I, Item 1 of this Form 10-Q.

Corporate General and Administrative (“CG&A”) Expenses

CG&A expenses increased $0.9 million for the three months ended October 1, 2022 compared to the three months ended October 2, 2021 primarily due to higher compensation and benefits costs of $1.0 million.

CG&A expenses decreased $0.7 million for the nine months ended October 1, 2022 compared to the nine months ended October 2, 2021 primarily due to lower compensation and benefits costs of $0.6 million.

Backlog

We define backlog as customer placed purchase orders (“POs”) and long-term agreements (“LTAs”) with firm fixed price and expected delivery dates of 24 months or less. The majority of the LTAs do not meet the definition of a contract under ASC 606 and thus, the backlog amount disclosed below is greater than the remaining performance obligations amount disclosed in Note 1 to our condensed consolidated financial statements included in Part I, Item 1 of this Form 10-Q. Backlog is subject to delivery delays or program cancellations, which are beyond our control. Backlog is affected by timing differences in the placement of customer orders and tends to be concentrated in several programs to a greater extent than our net revenues. Backlog in industrial markets tends to be of a shorter duration and is generally fulfilled within a three month period. As a result of these factors, trends in our overall level of backlog may not be indicative of trends in our future net revenues.

The increase in backlog was primarily in the commercial aerospace end-use market, partially offset by a decrease in the military and space end-use market. $688.0 million of total backlog is expected to be delivered over the next 12 months. The following table summarizes our backlog as of October 1, 2022 and December 31, 2021:

(Dollars in thousands)

Consolidated Ducommun Change October 1, 2022 December 31, 2021
Military and space $(53,443) $466,835 $520,278
Commercial aerospace 97,990 431,097 333,107
Industrial 4,491 56,293 51,802
Total $49,038 $954,225 $905,187
Electronic Systems
Military and space $(35,589) $364,413 $400,002
Commercial aerospace 53,073 109,883 56,810
Industrial 4,491 56,293 51,802
Total $21,975 $530,589 $508,614
Structural Systems
Military and space $(17,854) $102,422 $120,276
Commercial aerospace 44,917 321,214 276,297
Total $27,063 $423,636 $396,573

34

Liquidity and Capital Resources

Available Liquidity

Total debt, the weighted-average interest rate, cash and cash equivalents and available credit facilities were as follows:

(Dollars in millions)

October 1, 2022 December 31, 2021
Total debt, including long-term portion $250.0 $287.7
Weighted-average interest rate on debt 3.91% 3.27%
Term Loans interest rate 3.81% 3.22%
Cash and cash equivalents $21.2 $76.3
Unused Revolving Credit Facility $199.8 $99.8

On July 14, 2022, we completed a refinancing of all our existing debt by entering into a new term loan (“2022 Term Loan”) and a new revolving credit facility (“2022 Revolving Credit Facility”). The 2022 Term Loan is a $250.0 million senior secured loan that matures on July 14, 2027. The 2022 Revolving Credit Facility is a $200.0 million senior secured revolving credit facility that matures on July 14, 2027. The 2022 Term Loan and 2022 Revolving Credit Facility, collectively are the new credit facilities (“2022 Credit Facilities”). In conjunction with the closing of the 2022 Credit Facilities, we utilized the entire $250.0 million of proceeds from the 2022 Term Loan plus our existing cash on hand to pay off our entire debt balance outstanding of $254.2 million under prior credit facilities. At the same leverage ratio, the interest rate spread in the 2022 Credit Facilities is lower than the interest rate spread under our prior credit facilities. Interest payments are typically paid on a quarterly basis, on the last business day each quarter. In addition, the 2022 Term Loan requires quarterly amortization payments of 0.625% during year one and year two, 1.250% during year three and year four, and 1.875% during year five of the original outstanding principal balance of the 2022 Term Loan amount, on the last business day each quarter. Further, the undrawn portion of the commitment of the 2022 Revolving Credit Facility is subject to a commitment fee ranging from 0.175% to 0.275%, based upon the consolidated total net adjusted leverage ratio, typically paid on a quarterly basis, on the last business day each quarter. However, the 2022 Revolving Credit Facility does not require any principal installment payments. As of October 1, 2022, we were in compliance with all covenants required under the 2022 Credit Facilities. See Note 7 to our condensed consolidated financial statements included in Part I, Item 1 of this Form 10-Q for further information.

During the three months ended April 2, 2022, we paid down our existing debt an aggregate total of $30.0 million. We also made the mandatory quarterly amortization payments under our existing debt during the three and six months ended July 2, 2022 of $1.8 million and $3.5 million, respectively. No mandatory quarterly amortization payment was required to be paid on the 2022 Term Loan during the three months ended October 1, 2022, however, it will begin in the three months ending December 31, 2022. We made no other voluntary prepayments during the three and nine months ended October 1, 2022.

In April 2022, management approved and commenced a restructuring plan that will position us for stronger performance. The restructuring plan will mainly reduce headcount and consolidate facilities. As a result of this restructuring plan, we analyzed the need to write-down inventory and impair long-lived assets, including operating lease right-of-use assets. As of October 1, 2022, we estimate the remaining amount of charges related to this initiative to be $7.0 million to $10.0 million in total pre-tax restructuring charges through 2023. Of these charges, we estimate $5.0 million to $7.0 million to be cash payments for employee separation and other facility consolidation related expenses, and $2.0 million to $3.0 million to be non-cash charges for impairment of long-lived assets. On an annualized basis, we anticipate these restructuring actions will result in total cost savings of $7.0 million to $9.0 million. See Note 3 to our condensed consolidated financial statements included in Part I, Item 1 of this Form 10-Q for further information.

In November 2021, we entered into derivative contracts, U.S. dollar-one month LIBOR forward interest rate swaps designated as cash flow hedges, all with an effective date of January 1, 2024, for an aggregate total notional amount of $150.0 million, weighted average fixed rate of 1.8%, and all terminating on January 1, 2031 (“Forward Interest Rate Swaps”). The Forward Interest Rate Swaps mature on a monthly basis, with fixed amount payer payment dates on the first day of each calendar month, commencing on February 1, 2024 through January 1, 2031. See Note 1 and Note 7 to our condensed consolidated financial statements included in Part I, Item 1 of this Form 10-Q for further information.

On July 14, 2022, as a result of completing a refinancing of our existing debt, we were required to complete an amendment of the Forward Interest Rate Swaps (“Amended Forward Interest Rate Swaps”). The Forward Interest Rate Swaps were based on U.S. dollar-one month LIBOR and were amended to be based on one month Term SOFR as borrowings using LIBOR are no longer available under the 2022 Credit Facilities. The Amended Forward Interest Rate Swaps weighted average fixed rate is 1.7%, as a result of the difference between U.S. dollar-one month LIBOR and one month Term SOFR. See Note 1 and Note 7 to our condensed consolidated financial statements included in Part I, Item 1 of this Form 10-Q for further information.

In December 2021, we acquired MagSeal for a purchase price of $69.5 million, net of cash acquired, all payable in cash. Upon the closing of the transaction, we paid a gross total aggregate of $71.3 million in cash, a portion of which was by drawing down on our revolving credit facility. This draw down on our revolving credit facility was paid off by December 31, 2021. See Note 2 to our condensed consolidated financial statements included in Part I, Item 1 of this Form 10-Q for further information.

In December 2021, we entered into a sale-leaseback transaction for the building and related land for our Gardena performance center located in Carson, California (“Sale-Leaseback Agreement”). The building and related land was sold for $141.3 million and we recognized a gain of $132.5 million. As part of the Sale-Leaseback Agreement, we entered into an initial five year lease for the usage of the just sold building and related land. The future minimum base monthly lease payments during the initial five year period in aggregate total $19.6 million.

We expect to spend a total of $16.0 million to $18.0 million for capital expenditures in 2022 (excluding capital expenditures we will spend to restore the manufacturing capabilities related to our Guaymas performance center that was severely damaged by fire in June 2020), financed by cash generated from operations, principally to support new contract awards in the Electronic Systems and Structural Systems segments. As part of our strategic plan to become a supplier of a wider range of higher-level assemblies and win new contract awards, additional up-front investment in tooling will be required for newer programs which have higher engineering content and higher levels of complexity in assemblies.

We believe the ongoing aerospace and defense subcontractor consolidation makes acquisitions an increasingly important component of our future growth. We will continue to make prudent acquisitions and capital expenditures for manufacturing equipment and facilities to support long-term contracts for commercial and military aircraft and defense programs.

We monitor our asset base, including the market dynamics of the properties we own, and we may sell such properties and/or enter into sale-leaseback transactions. Such transactions would provide cash for various capital deployment options.

We continue to depend on operating cash flow and the availability of our 2022 Credit Facilities to provide short-term liquidity. Cash generated from operations and bank borrowing capacity is expected to provide sufficient liquidity to meet our obligations during the next twelve months from the date of issuance of these financial statements.

Cash Flow Summary

Net cash provided by operating activities for the nine months ended October 1, 2022 was $0.6 million, compared to net cash used in operating activities of $12.3 million for the nine months ended October 2, 2021. The higher net cash provided by operating activities during the first nine months of 2022 was mainly due to higher accounts payable, partially offset by higher inventories, higher accounts receivable, higher contract assets, and lower net income.

Net cash used in investing activities was $13.9 million for the nine months ended October 1, 2022, compared to $9.8 million in the nine months ended October 2, 2021. The higher net cash used during the first nine months of 2022 compared to the prior year period was mainly due to higher purchases of property and equipment.

Net cash used in financing activities was $41.8 million for the nine months ended October 1, 2022, compared to $25.4 million for the nine months ended October 2, 2021. The higher net cash used in financing activities during the first nine months of 2022 was mainly due to the $37.7 million, net pay down on term loans during the nine months ended October 1, 2022.

Off-Balance Sheet Arrangements

Our off-balance sheet arrangements consist of operating and finance leases not recorded as a result of the practical expedients utilized, right of offset of industrial revenue bonds and associated failed sales-leasebacks on property and equipment, and indemnities, none of which we believe may have a material current or future effect on our financial condition, liquidity, capital resources, or results of operations.

Critical Accounting Policies

The preparation of our condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States requires estimation and judgment that affect the reported amounts of net revenues, expenses, assets and liabilities. For a description of our critical accounting policies, please refer to “Critical Accounting Policies” in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our 2021 Annual Report on Form 10-K. There have been no material changes in any of our critical accounting policies during the three months ended October 1, 2022.

Recent Accounting Pronouncements

See “Part I, Item 1. Ducommun Incorporated and Subsidiaries—Notes to Condensed Consolidated Financial Statements—Note 1. Summary of Significant Accounting Policies—Recent Accounting Pronouncements” for further information.

Market risk

As filed, 1,464 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our main market risk exposure relates to changes in U.S. interest rates on our outstanding long-term debt. At October 1, 2022, we had total borrowings of $250.0 million under our 2022 Credit Facilities.

The 2022 Term Loan bears interest, at our option, at a rate equal to either (i) Term Secured Overnight Financing Rate (“Term SOFR”) plus an applicable margin ranging from 1.375% to 2.375% per year or (ii) Base Rate (defined as the highest of [a] Federal Funds Rate plus 0.50%, [b] Bank of America’s prime rate, and [c] Term SOFR plus 1.00%, and if the Base Rate is less than zero percent, it will be deemed zero percent) plus an applicable margin ranging from 0.375% to 1.375% per year, in each case based upon the consolidated total net adjusted leverage ratio.

The 2022 Revolving Credit Facility bears interest, at our option, at a rate equal to either (i) Term SOFR plus an applicable margin ranging from 1.375% to 2.375% per year or (ii) Base Rate (defined as the highest of [a] Federal Funds Rate plus 0.50%, [b] Bank of America’s prime rate, and [c] Term SOFR plus 1.00%, and if the Base Rate is less than zero percent, it will be deemed zero percent) plus an applicable margin ranging from 0.375% to 1.375% per year, in each case based upon the consolidated total net adjusted leverage ratio.

A hypothetical 10% increase or decrease in the interest rate would have an immaterial impact on our financial condition and results of operations.

Controls and procedures

As filed, 713 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Disclosure Controls and Procedures

The Company’s chief executive officer (“CEO”) and chief financial officer (“CFO”) have conducted an evaluation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934), and concluded that such disclosure controls and procedures were effective as of the end of the period covered by this report.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the three months ended October 1, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 674 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

See Part I, Item 1A of our Annual Report on Form 10-K (“Form 10-K”) for the year ended December 31, 2021 for a discussion of our risk factors. There have been no material changes during the three months ended October 1, 2022 to the risk factors disclosed in our Form 10-K for the year ended December 31, 2021.

Macroeconomic trends including inflation and rising interest rates may adversely affect our financial condition and results of operations.

Macroeconomic trends, including increases in inflation and rising interest rates, may adversely impact our business, financial condition and results of operations. Inflation in the United States has recently accelerated

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-10-01. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-07-03 to 2022-10-01$186.6mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2022-01-01 to 2022-10-01$524.3mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2022-07-03 to 2022-10-01$148.0mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2022-01-01 to 2022-10-01$418.6mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2022-07-03 to 2022-10-01$38.6mus-gaap:GrossProfit
Gross profit9 months2022-01-01 to 2022-10-01$105.7mus-gaap:GrossProfit
Selling, general and administrative3 months2022-07-03 to 2022-10-01$24.8mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2022-01-01 to 2022-10-01$72.3mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2022-07-03 to 2022-10-01$13.2mus-gaap:OperatingIncomeLoss
Operating income9 months2022-01-01 to 2022-10-01$30.1mus-gaap:OperatingIncomeLoss
Income tax3 months2022-07-03 to 2022-10-01$1.5mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2022-01-01 to 2022-10-01$4.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-07-03 to 2022-10-01$8.5mus-gaap:NetIncomeLoss
Net income9 months2022-01-01 to 2022-10-01$20.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2022-07-03 to 2022-10-01$0.69us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2022-01-01 to 2022-10-01$1.68us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-07-03 to 2022-10-01$0.70us-gaap:EarningsPerShareBasic
Basic EPS9 months2022-01-01 to 2022-10-01$1.72us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-07-03 to 2022-10-0112,350,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2022-01-01 to 2022-10-0112,346,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2022-01-01 to 2022-10-01$630.0kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2022-01-01 to 2022-10-01$14.4mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2022-10-01$21.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-10-01$499.1mus-gaap:AssetsCurrent
Total assetsAt period end2022-10-01$989.5mus-gaap:Assets
Current liabilitiesAt period end2022-10-01$181.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-10-01$480.7mus-gaap:Liabilities
Long-term debtAt period end2022-10-01$243.8mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2022-10-01$6.3mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2022-10-01$508.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001628280-22-028529. Last ingested by Listed: Nov 10, 2026, 01:39 ET. Listed shows no prices and gives no investment advice.